Joseph S. Shan

2018

In 2018, Joseph S. Shan earned a total compensation of $601.5K as Former Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals, a 18% increase compared to previous year.

Compensation breakdown

Salary$219,865
Other$381,608
Total$601,473

Shan received $381.6K in other compensation, accounting for 63% of the total pay in 2018.

Shan also received $219.9K in salary.

Rankings

In 2018, Joseph S. Shan's compensation ranked 11,273rd out of 14,244 executives tracked by ExecPay. In other words, Shan earned more than 20.9% of executives.

ClassificationRankingPercentile
All
11,273
out of 14,244
21st
Division
Manufacturing
4,564
out of 5,765
21st
Major group
Chemicals And Allied Products
1,733
out of 2,128
19th
Industry group
Drugs
1,472
out of 1,817
19th
Industry
Pharmaceutical Preparations
1,129
out of 1,391
19th
Source: SEC filing on August 17, 2018.

Shan's colleagues

We found four more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2018.

2018

Roger Lias

Peregrine Pharmaceuticals

Chief Executive Officer

2018

Steven King

Peregrine Pharmaceuticals

Chief Executive Officer

2018

Paul Lytle

Peregrine Pharmaceuticals

Chief Financial Officer

2018

Mark Ziebell

Peregrine Pharmaceuticals

General Counsel

News

You may also like